{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:32Z","timestamp":1787020112341,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cystic echinococcosis (CE) is a chronic disease considered a neglected one. Cystic echinococcosis is endemic in Uruguay and the region. Surgery, using various technical approaches, has the potential to safely remove the cyst(s) and lead to a complete cure in a high number of patients with simple forms of CE. However, surgery may be impractical in patients with multiple cysts in several organs, high surgical risk, or in patients with previous multiple surgeries. In these cases, the pharmacological treatment with the benzimidazolic drug Albendazole (ABZ) alone or combined with Praziquantel (PZQ), has been promising as the best choice to achieve improvement or cure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we analyze the results obtained on the anti-parasitic treatment of 43 patients diagnosed with CE between the years 2003 and 2020. Patients were treated before and\/or after surgery with ABZ or the combination ABZ\/PZQ. The standardize protocol of the anti-parasitic drug treatment before surgery was 7 days, 15 days or 1 month depending on the urgency and availability of the surgical procedure. All cases that involved confirmed locations on lungs underwent immediate surgery with minimal pre-treatment when possible. After surgery, the standardize protocol of anti-parasitic drug treatment consisted of six cycles of 30 days each and resting intervals of 15 days in between. ABZ was used in all cases, administered orally, twice daily, at a total dosage of 15\u00a0mg\/kg\/day, with food high in fat content for improved absorption. The follow up was carried out according to WHO-IWGE guidelines for 5 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 43 patients fourteen were \u2264\u200915 years of age and had a differentiated pre-surgical treatment. From the \u2265\u200916 years of age, 36 completed the treatments and the 5 years follow up. Four patients changed geographical locations, without a forwarding contact, after the post-surgery treatment. No patient died during the study. Of the 36 patients that completed the study, 32 were treated only with ABZ; 93.75% achieved treatment success as determined by improvement or cure, and 6.25% treatment failure determined by no change or worsening. The last four patients received the ABZ\/PZQ combination therapy and achieved 100% treatment success.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The pharmacological treatment resulted in a good option not only as palliative but also as potentially curative. The main relevance of its use was in cases with previous multiple surgeries or surgeries with potential life-threatening complications due to the number and location of cysts and concurrent comorbidities. A follow-up of at least 5 years would be recommended to assure remission and control of the transmission. More randomized trials are needed to provide clear clinical evidence of different pharmacological treatments for CE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-024-09539-y","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T10:05:46Z","timestamp":1721988346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Follow up study of symptomatic human cystic echinococcosis treatment with albendazole and praziquantel, in Uruguay"],"prefix":"10.1186","volume":"24","author":[{"given":"Daniel Da","family":"Rosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Figueredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Go\u00f1i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"9539_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.24039\/rnh2007121153","volume":"1","author":"C Ferreira","year":"2007","unstructured":"Ferreira C, Irabedra P. Cystic echinococcosis as a public health problem in latin American and new approaches is its control. Neotrop Helminthol. 2007;1:55\u20137.","journal-title":"Neotrop Helminthol"},{"issue":"6","key":"9539_CR2","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1590\/0074-02760160070","volume":"111","author":"P Irabedra","year":"2016","unstructured":"Irabedra P, Ferreira C, Sayes J, Elola S, et al. Control programme for cystic echinococcosis in Uruguay. Mem Inst Oswaldo Cruz Rio De Janeiro. 2016;111(6):372\u20137.","journal-title":"Mem Inst Oswaldo Cruz Rio De Janeiro"},{"key":"9539_CR3","unstructured":"Division Epidemiology. Department of Health. Hospitable Departures CIE 10. 2022."},{"key":"9539_CR4","doi-asserted-by":"publisher","unstructured":"Da Rosa D, Mar\u00eda Acu\u00f1aA, Figueredo, Elisa, Calegari, Luis, Mart\u00ednez, Luis Ruso. Clinical management of the hepatic cystic echinococcus, stage CE3b, combining medical treatment-surveillance strategy and waiting: a case report Rev M\u00e9d Urug,. 2017; 33(4):269\u2013273 http:\/\/www.rmu.org.uy\/revista\/33\/4\/2\/es\/7\/https:\/\/doi.org\/10.29193\/RMU.34.3.8","DOI":"10.29193\/RMU.34.3.8"},{"key":"9539_CR5","doi-asserted-by":"publisher","first-page":"e00075","DOI":"10.1128\/CMR.00075-18","volume":"32","author":"H Wen","year":"2019","unstructured":"Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W, McManus DP. Echinococcosis: Adv in the 21st century. Clin Microbiol Rev. 2019;32:e00075\u201318. https:\/\/doi.org\/10.1128\/CMR.00075-18","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"9539_CR6","doi-asserted-by":"publisher","first-page":"e524","DOI":"10.1371\/journal.pntd.0000524","volume":"3","author":"M Stojkovic","year":"2009","unstructured":"Stojkovic M, Zwahlen M, Teggy A, Vutova K, Cretu CM, et al. Treatment response of cystic echinococcosis to Benzimidazoles: a systematic review. PLOS Neglected Trop Disease. 2009;3(9):e524.","journal-title":"PLOS Neglected Trop Disease"},{"key":"9539_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actatropica.2009.11.001","volume":"114","author":"E Brunetti","year":"2010","unstructured":"Brunetti E, Peter K, Vuitton D. Writing panel for the WHO-IWGE. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010;114:1\u201316.","journal-title":"Acta Trop"},{"key":"9539_CR8","volume-title":"Geneva, Switzerland, 15\u201316 December 2016","author":"Meeting of the WHO Informal Working Group on Echinococcosis (WHO-IWGE)","year":"2017","unstructured":"Meeting of the WHO Informal Working Group on Echinococcosis (WHO-IWGE). Geneva, Switzerland, 15\u201316 December 2016. Geneva, Switzerland: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. WHO\/HTM\/ NTD\/NZD\/2017.01."},{"issue":"6","key":"9539_CR9","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.4269\/ajtmh.2011.11-0382","volume":"85","author":"JL Salinas","year":"2011","unstructured":"Salinas JL, Gonzalez HV, Arce-Villavicencio Y, Carbajal-Gonzalez D, Talledo L, Willig JH. Long-term albendazole effectiveness for hepatic cystic echinococcosis. Am J Trop Hyg. 2011;85(6):1075\u20139.","journal-title":"Am J Trop Hyg"},{"issue":"5","key":"9539_CR10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.4269\/ajtmh.13-0059","volume":"90","author":"L Suares","year":"2014","unstructured":"Suares L, Velasco V, Belhassen M, Novo I, Pardo J, et al. Safety of the combined use of Praziquantel and Albendazol in the treatment of human hydatid disease. Am J Trop Hyg. 2014;90(5):819\u201322.","journal-title":"Am J Trop Hyg"},{"issue":"10","key":"9539_CR11","doi-asserted-by":"publisher","first-page":"e1880","DOI":"10.1371\/journal.pntd.0001880","volume":"6","author":"M Stojkovic","year":"2012","unstructured":"Stojkovic M, Rosenberger K, Kauczor H-U, Junghanss T, Hosch W. Diagnosing and staging of cystic echinococcosis: how do CT and MRI perform in comparison to Ultrasound? PLOS Neglected Trop Disease. 2012;6(10):e1880.","journal-title":"PLOS Neglected Trop Disease"},{"key":"9539_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4269\/ajtmh.2008.79.301","volume":"79","author":"T Junghanss","year":"2008","unstructured":"Junghanss T, Menezes da Silva A, Horton J, Chiodini PL, Brunetti E. Clinical management of cystic echinococcosis: state of the art, problems, and perspectives. Am J Trop Med Hyg. 2008;79:301\u201311.","journal-title":"Am J Trop Med Hyg"},{"key":"9539_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0035-9203(00)90455-3","volume":"94","author":"R Bonifacino","year":"2000","unstructured":"Bonifacino R, Carter DS, Craig PS, Almeida I, Da Rosa WD. Assessment of the immunological surveillance value of humoral and lymphocyte assay in severe human cystic echinococcosis. Trans R Soc Trop Med Hyg. 2000;94:97\u2013102.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"9539_CR14","doi-asserted-by":"crossref","unstructured":"Zhang W, Wen H, Li J, Lin R, McManus DP. Immunology and Immunodiagnosis of cystic echinococcosis: An Update. Clin and Develop. Immunol. 2012; ID 101895. 1\u201310.","DOI":"10.1155\/2012\/101895"},{"key":"9539_CR15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1128\/JCM.02420-15","volume":"54","author":"NI Agudelo Higuita","year":"2016","unstructured":"Agudelo Higuita NI, Brunetti E, McCloskey C. Cystic echinococcosis. J Clin Microbiol. 2016;54:518\u201323. https:\/\/doi.org\/10.1128\/JCM.02420-15","journal-title":"J Clin Microbiol"},{"key":"9539_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1472-8206.2003.00171.x","volume":"17","author":"J Horton","year":"2003","unstructured":"Horton J. Albendazole for the Treatment of Echinococcosis. Fundamental Clin Pharmacol. 2003;17:205\u201312. https:\/\/doi.org\/10.1046\/j.1472-8206.2003.00171.x","journal-title":"Fundamental Clin Pharmacol"},{"key":"9539_CR17","doi-asserted-by":"publisher","unstructured":"Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W, McManus DP. 2019. Echinococcosis: advances in the 21st century. Clin Microbiol Rev 2019; 32:e00075-18. https:\/\/doi.org\/10.1128\/CMR.00075-18","DOI":"10.1128\/CMR.00075-18"},{"issue":"9","key":"9539_CR18","doi-asserted-by":"publisher","first-page":"e0008566","DOI":"10.1371\/journal.pntd.0008566","volume":"14","author":"F Tamarozzi","year":"2020","unstructured":"Tamarozzi F, Horton J, Muhtarov M, Ramharter M, Siles-Lucas M, Gruener B, et al. A case for adoption of continuous albendazole treatment regimen for human echinococcal infections. PLoS Negl Trop Dis. 2020;14(9):e0008566. https:\/\/doi.org\/10.1371\/journal.pntd.0008566","journal-title":"PLoS Negl Trop Dis"},{"key":"9539_CR19","doi-asserted-by":"publisher","unstructured":"Franchi C, Di Vico B, Teggi A. Long-term evaluation of patients with hydatidosis treated with benzimidazole carbamates. Clin Infect Dis. 1999; 29(2):304\u2013309. https:\/\/doi.org\/10.1086\/520205 PMID: 10476732.","DOI":"10.1086\/520205"},{"issue":"1","key":"9539_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1128\/CVI.00363-07","volume":"15","author":"A Hernandez","year":"2008","unstructured":"Hernandez A, Muro A, Barrera I, Ramos G, Ordu\u00f1a A, Siles Lucas M. Usefulness of four different Echinococcus granulosus recombinant antigens for serodiagnosis of Unilocular Hydatid Disease (UHD) and Postsurgical Follow-Up of patients treated for UHD. Clin Vaccine Immunol. 2008;15(1):147\u201353.","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"9539_CR21","doi-asserted-by":"publisher","first-page":"e0009648","DOI":"10.1371\/journal.pntd.0009648","volume":"15","author":"L Petrone","year":"2021","unstructured":"Petrone L, Tamarozzi F, Vola A, Gomez Morales MA, Ludovisi A, Najafi Fard S, et al. Accuracy of an experimental whole-blood test for detecting reactivation of echinococcal cysts. PLoS Negl Trop Dis. 2021;15(8):e0009648. https:\/\/doi.org\/10.1371\/journal.pntd.0009648","journal-title":"PLoS Negl Trop Dis"},{"key":"9539_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/00034983.1994.11812870","volume":"88","author":"J Nahmias","year":"1994","unstructured":"Nahmias J, Goldsmith R, Soibelman M, el-On J. Three- to 7-year follow-up after albendazole treatment of 68 patients with cystic echinococcosis (hydatid disease). Ann Trop Med Parasitol. 1994;88:295\u2013304.","journal-title":"Ann Trop Med Parasitol"},{"issue":"3","key":"9539_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4269\/ajtmh.2008.79.301","volume":"79","author":"T Junghanss","year":"2008","unstructured":"Junghanss T, Menezes da Silva A, Horton J, Chiodini PL, Brunetti E. Clinical management of cystic echinococcosis: state of the art, problems and perspectives. Am J Trop Med Hyg. 2008;79(3):301\u201311.","journal-title":"Am J Trop Med Hyg"},{"key":"9539_CR24","doi-asserted-by":"publisher","unstructured":"Larrieu E, Uchiumi L, Salvitti JC, Sobrino M, Panomarenko O, Tissot H et al. Epidemiology, diagnosis, treatment and follow-up of cystic echinococcosis in asymptomatic carriers. Trans R Soc Trop Med Hyg. 2019; 113(2):74\u201380. https:\/\/doi.org\/10.1093\/trstmh\/try112 PMID: 30412239.","DOI":"10.1093\/trstmh\/try112"},{"key":"9539_CR25","doi-asserted-by":"publisher","unstructured":"Kern P, Menezes da Silva A, Akhan O, M\u00fcllhaupt B, Vizcaychipi KA, Budke C, Vuitton DA. Chapter Four - The Echinococcoses: Diagnosis, Clinical Management and Burden of Disease, Editor(s): R.C.A. Thompson, P. Deplazes, A.J. Lymbery, Advances in Parasitology, Academic Press, 2017; Volume 96, 259\u2013369,ISSN 0065-308X,ISBN 9780128123997,https:\/\/doi.org\/10.1016\/bs.apar.2016.09.006","DOI":"10.1016\/bs.apar.2016.09.006"},{"key":"9539_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1586\/14787210.7.2.145","volume":"7","author":"DA Vuitton","year":"2009","unstructured":"Vuitton DA. Benzimidazoles for the treatment of cystic and alveolar echinococcosis: what is the consensus? Expert Rev Anti Infect Ther. 2009;7:145\u20139. https:\/\/doi.org\/10.1586\/14787210.7.2.145","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"5","key":"9539_CR27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.4269\/ajtmh.13-0059","volume":"90","author":"L Alvela-Su\u00e1rez","year":"2014","unstructured":"Alvela-Su\u00e1rez L, Velasco-Tirado V, Belhassen-Garcia M, Novo-Veleiro I, Pardo-Lled\u00edas J, et al. Safety of the combined use of Praziquantel and Albendazole in the treatment of human hydatid disease. Am J Trop Med Hyg. 2014;90(5):819\u201322.","journal-title":"Am J Trop Med Hyg"},{"key":"9539_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00436-008-0954-z","volume":"103","author":"M Jamshidi","year":"2008","unstructured":"Jamshidi M, Mohraz M, Zangeneh M, et al. The effect of combination therapy with albendazole and praziquantel on hydatid cyst treatment. Parasitol Res. 2008;103:195\u20139. https:\/\/doi.org\/10.1007\/s00436-008-0954-z","journal-title":"Parasitol Res"},{"key":"9539_CR29","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1007\/s00436-016-5054-x","volume":"115","author":"F L\u00f6tsch","year":"2016","unstructured":"L\u00f6tsch F, Naderer J, Skuhala T, Groger M, Auer H, Kaczirek K, Waneck F, Ramharter M. Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data. Parasitol Res. 2016;115:2995\u2013DOI3001. https:\/\/doi.org\/10.1007\/s00436-016-5054-x","journal-title":"Parasitol Res"},{"key":"9539_CR30","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/00007691-200206000-00003","volume":"24","author":"VL Lanchote","year":"2002","unstructured":"Lanchote VL, Garc\u00eda FS, Dreossi SA, Takayanagui OM. Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. Thar Drug Monit. 2002;24:338\u201345.","journal-title":"Thar Drug Monit"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09539-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09539-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09539-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T10:06:34Z","timestamp":1721988394000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09539-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9539"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09539-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"assertion":[{"value":"5 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that all the methods have been followed according to the pertinent guidelines and regulations in our country, and with the international norms.The Ethics Committee of the School of Medicine UDELAR approved the protocol in the year 2000.Informed written consent was obtained from all subjects in the study. From the <\u200918 years old patients, informed written consent was obtained from the parents and\/or their legal guardian(s).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Assign ISRCTN to trial - standard fee\n                      \n                      .02\/08\/2023 ISRCTN78387420 Pre- and post-surgical medical treatment of human cystic echinococcosis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"\u2022 WHO International Clinical Trial Registry platform"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"737"}}